Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Study of the Glutaminase Inhibitor CB-839 in Leukemia [Phase 1]
This document provides a Phase 1 trial update for CB-839, a glutaminase inhibitor, in patients with acute myeloid leukemia and acute lymphob…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia [Phase 3]
A Phase 3 clinical trial evaluating combination chemotherapy in children with newly diagnosed acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
Update on a Phase 1/2 study of blinatumomab in children and adolescents with relapsed or refractory B-precursor acute lymphoblastic leukemia…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients [NA]
A completed clinical trial evaluating the effectiveness of the neutropenic diet in pediatric oncology patients, including acute lymphoblasti…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALL [Phase 3]
Phase 3 trial assessing glucarpidase impact on severe delayed HDM clearance in children with high-dose methotrexate-treated acute lymphoblas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]
Phase 2 trial evaluating bortezomib in combination chemotherapy for relapsed acute lymphoblastic leukemia or lymphoblastic lymphoma in child…
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247) [Phase 1]
Phase 1 study of SCH 900776 (MK-8776) with and without cytarabine in acute leukemias; the trial is terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: CART-19 Cells For MRD Positive CD19+ ALL [Phase 2, Phase 3]
An update on CART-19 cell therapy for MRD-positive CD19+ acute lymphoblastic leukemia, conducted across Phase 2 and Phase 3. The sponsor is …
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT [Phase 1, Phase 2]
The document reports the completion of a Phase 1/2 trial evaluating a TCR alpha-beta depleted graft in pediatric patients with acute lymphob…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Home-exercise Program for Children and Adolescent Survivors of Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
The clinical trial update notes the completion of a Phase 1/Phase 2 study evaluating a home-exercise program for children and adolescents wh…
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias
This completed clinical trial investigates protein biomarker profiles in neutropenic fever/infection among patients with acute or chronic le…
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL
Clinical trial update notes pancreatitis, hepatotoxicity and hyperlipidemia associated with PEG-asparaginase in children with acute lymphobl…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) [Phase 1]
Phase 1 clinical trial update evaluating peg-aspargase with combination chemotherapy in younger patients with newly diagnosed high-risk acut…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma [Phase 1, Phase 2]
Clinical trial update describing the evaluation of PCAR-119 Bridge Immunotherapy as a pre-transplant treatment for CD19-positive leukemias a…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Rapamycin in Relapsed Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 trial of Rapamycin for relapsed acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents [Phase 4]
Phase 4 pharmacokinetic study of PEG-rhG-CSF in children and adolescents with acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma [Phase 1, Phase 2]
Clinical trial update on CD19-targeted CAR-T cell therapy being tested in relapsed/refractory leukemias and lymphomas (Phase 1 and Phase 2).
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Statin Therapy in Young Adult Survivors of Childhood Cancer [Phase 2]
Phase 2 clinical trial update evaluating statin therapy for cardiovascular risk reduction in young adult survivors of childhood cancer; the …
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 clinical trial evaluating CART-19 cell therapy for B cell acute lymphoblastic leukemia, reporting efficacy signals.
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating dasatinib in combination with chemotherapy for newly diagnosed acute lymphoblastic leukemia, including B…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia [EARLY_Phase 1]
An early-phase trial investigates using granulocyte colony-stimulating factor (G-CSF) to disrupt the bone marrow microenvironment in acute l…
-
CLINICAL_TRIALS trial_result · 2016-09-12Clinical Trial Update: Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit [Phase 1]
This update reports the completion of a Phase 1 trial evaluating a single treatment with FT1050, an ex-vivo modulated umbilical cord blood u…
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Dasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic Leukemia [Phase 2]
A phase 2 trial evaluating dasatinib with low-intensity chemotherapy for Philadelphia chromosome–positive acute lymphoblastic leukemia has c…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Umbilical Cord Blood Transplant for Hematological Malignancies [Phase 1]
Phase 1 clinical trial evaluating umbilical cord blood transplantation for hematologic malignancies has completed enrollment and reporting.
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation [Phase 2]
Phase 2 trial update evaluating immunotherapy for relapse after allogeneic transplantation in acute myeloid leukemia, acute lymphoblastic le…